Article
Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts.
PloS one - 1 Jan 2012
Seitz Sebastian, Keller Johannes, Schilling Arndt F, Jeschke Anke, Marshall Robert P, Stride Brenda D, Wintermantel Tim, Beil Frank T, Amling Michael, Schütz Günther, Tuckermann Jan, Schinke Thorsten
Abstract excerpt
Postmenopausal osteoporosis is characterized by declining estrogen levels, and estrogen replacement therapy has been proven beneficial for preventing bone loss in affected women. While the physiological functions of estrogen in bone, primarily the inhibition of bone resorption, have been studied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
